drugset

drugset / Trial / NCT00288197

A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections

NCT00288197 ↗

Phase 4 Completed 77 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy and safety of voriconazole in Chinese patients with proven or probable deep tissue fungal infections.

Timeline

Start: 2006-01
Primary completion: 2007-06
Completion: 2007-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Voriconazole	Small molecule	—	—

Indications